Search By

Format
Articles (119)Events (28)News (1545)Interviews (79)
Publication Date

1,545 Results

Search By

ArticlesEventsNewsInterviews

Horphag Research Positions Pycnogenol as Multifunctional Core Ingredient for Women's Health Formulations

Horphag Research advances Pycnogenol® as a multi-claim women's health ingredient backed by 160+ clinical studies across skin, menopause, circulation, and joints.

Vaibhavi M. | Jun 16, 2026

Koi Peptides Launches BPC-157 and TB-500 Research Blend with Per-Lot Certificate of Analysis

Koi Peptides releases a lyophilized BPC-157/TB-500 research blend with per-lot CoA documentation for laboratory traceability.

Vaibhavi M. | Jun 16, 2026

FibroBiologics Achieves First Patient Dosing in CYWC628 Phase 1/2 Trial for Diabetic Foot Ulcers

FibroBiologics doses first patients in CYWC628 Phase 1/2 DFU trial while advancing a third consecutive GMP manufacturing run.

Vaibhavi M. | Jun 16, 2026

Amphastar Gains FDA OTC Approval for Rextovy 4mg Naloxone Nasal Spray in Opioid Overdose

FDA approves Amphastar's Rextovy 4mg OTC naloxone nasal spray, adding a second nonprescription option and raising manufacturing scale-up questions.

Vaibhavi M. | Jun 16, 2026

Allergan Aesthetics Gains FDA Approval for SKINVIVE Neck Indication, Its Second Cleared Use

Allergan Aesthetics secures FDA approval for SKINVIVE's neck indication, its second cleared use since 2023, with mandatory provider training required pre-purchase.

Vaibhavi M. | Jun 16, 2026

Cognition Therapeutics Secures Composition of Matter Patent for Zervimesine Extending Protection to 2045

Cognition Therapeutics receives USPTO Notice of Allowance for a polymorphic crystalline form patent on zervimesine, extending exclusivity through 2045.

Vaibhavi M. | Jun 16, 2026

3PBIOVIAN Positions Early CDMO Engagement as Core Risk Mitigation Strategy for AAV Gene Therapy Programs

3PBIOVIAN argues proof-of-concept CDMO engagement reduces regulatory risk and compresses timelines in AAV gene therapy manufacturing.

Vaibhavi M. | Jun 16, 2026